TipRanks
Go Ultimate55% OFF

Compare Oracle Healthcare Acquisition (OHAQ) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
OHAQOracle Healthcare Acquisition$0.01$1,3750.000.00%―Unlock the OHAQ analyst price target with TipRanks PremiumOHAQUnlock the OHAQ top-analyst price target with TipRanks Premium
AFJKAimei Health Technology Co., Ltd$12.20$38.63M178.886.88%―Unlock the AFJK analyst price target with TipRanks PremiumOHAQ vs AFJKUnlock the AFJK top-analyst price target with TipRanks Premium
UCFICN Healthy Food Tech Group$5.51$287.81M66.550.00%―Unlock the UCFI analyst price target with TipRanks PremiumOHAQ vs UCFIUnlock the UCFI top-analyst price target with TipRanks Premium
OACCOaktree Acquisition Corp. III Life Sciences Class A$10.72$263.53M37.911.13%―Unlock the OACC analyst price target with TipRanks PremiumOHAQ vs OACCUnlock the OACC top-analyst price target with TipRanks Premium
TDACTranslational Development Acquisition Corp.$10.82$208.92M42.003.54%―Unlock the TDAC analyst price target with TipRanks PremiumOHAQ vs TDACUnlock the TDAC top-analyst price target with TipRanks Premium
DMAADrugs Made In America Acquisition Corp.$10.89$264.38M55.485.52%―Unlock the DMAA analyst price target with TipRanks PremiumOHAQ vs DMAAUnlock the DMAA top-analyst price target with TipRanks Premium

Performance Comparison

-200%0%200%400%600%800%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
OHAQOracle Healthcare Acquisition0.010.000.00%
AFJKAimei Health Technology Co., Ltd12.200.907.96%
UCFICN Healthy Food Tech Group5.510.000.00%
OACCOaktree Acquisition Corp. III Life Sciences Class A10.720.121.14%
TDACTranslational Development Acquisition Corp.10.820.363.44%
DMAADrugs Made In America Acquisition Corp.10.890.575.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts